Grindr users report more sexual risk, but more likely to use PrEP
Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?
Oral cabotegravir and rilpivirine still effective at 312 weeks
Ibalizumab monoclonal antibody is effective in real-world use
Hepatitis C vaccine fails to prevent chronic infection
Do integrase inhibitors increase the risk of diabetes?
